Skip to content
DraconiticResearch
Search Sources API
186,123 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY-NC-NDCirculation Journal

Interpreting Low Pressure Pullback Gradient in Non-Culprit Lesions With Quantitative Flow Ratio ≥0.80 ― Reply ―

Abstract

with lipid-rich or vulnerable plaque characteristics, including in non-flow-limiting non-culprit lesions of patients with MI. 3,4 Conversely, from a prognostic standpoint, lower PPG or diffuse disease patterns have also been associated with adverse vessel-related outcomes after PCI. 5 Thus, plaque vulnerability and clinical prognosis may represent related but distinct aspects of coronary disease.Our original discussion was intended to raise the hypothesis that a lower QFR-PPG phenotype may reflect a broader disease burden in AMI non-IRA lesions, rather than to establish a direct mechanistic link between low QFR-PPG and vulnerable plaque morphology.Further studies integrating coronary physiology with systematic intravascular imaging are needed to clarify the underlying plaque phenotype.Taken together, we agree that QFR-PPG <0.78 should be interpreted as a data-derived prognostic threshold rather than as a definitive biological definition of diffuse disease or plaque vulnerability.At the same time, the additional analyses demonstrate that QFR-PPG provides prognostic information not fully captured by QFR within the nonischemic range, particularly when combined with relatively lower QFR values.We therefore believe that the QFR/ QFR-PPG phenotype is best interpreted as a prognostic physiological risk-stratification tool for deferred, functionally insignificant intermediate non-IRA lesions after AMI.

Related

  1. Interpreting Low Pressure Pullback Gradient in Non-Culprit Lesions With Quantitative Flow Ratio ≥0.80
    Masahiro Hoshino
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  2. Association of Multimodal Intracoronary Imaging-Derived Plaque Morphology with the Pathophysiological Disease Patterns Assessed by the Quantitative Flow Ratio-Pullback Pressure Gradient
    Eisuke Usui, Yoshihisa Kanaji, Masahiro Hada +12
    Journal of Atherosclerosis and ThrombosisPeer-reviewedCC BY-NC-SAFull textSurgery & anaesthesiaJ-STAGE
  3. Predictive models for trans-stenotic pressure gradient in the transverse sinus based on multimodal correlates
    Yan Huang, Linkun Cai, Xiaoyu Qiu +8
    Quantitative imaging in medicine and surgeryPeer-reviewedCC BY-NC-NDFull textMedical imaging & radiologyEurope PMC
  4. Innovative application of pressure gradient measurement in internal carotid stenosis in patients undergoing carotid artery stenting (NOTICE-CAS): study protocol for a randomized, assessor-blinded, parallel-group clinical trial
    Krzysztof Ściborski, Artur Telichowski, Natalia Świątoniowska-Lonc +19
    TrialsPeer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
  5. EUS-PPG Measured Distal to the Thrombus: A Reliable Way to Detect the Pressure Gradient in Patients With Cirrhosis and Portal Vein Thrombosis.
    Wei Wei, Laijuan Chen, Runya Ying +1
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy SocietyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
BibTeX
@article{nakao2026interpreting,
  title = {{Interpreting Low Pressure Pullback Gradient in Non-Culprit Lesions With Quantitative Flow Ratio ≥0.80 ― Reply ―}},
  author = {Sho Nakao and Takayuki Ishihara and Toshiaki Mano},
  journal = {Circulation Journal},
  year = {2026},
  month = aug,
  doi = {10.1253/circj.cj-26-0652},
  url = {https://www.jstage.jst.go.jp/article/circj/90/9/90_CJ-26-0652/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Interpreting Low Pressure Pullback Gradient in Non-Culprit Lesions With Quantitative Flow Ratio ≥0.80 ― Reply ―
AU  - Sho Nakao
AU  - Takayuki Ishihara
AU  - Toshiaki Mano
PY  - 2026
DA  - 2026/08/25
JO  - Circulation Journal
DO  - 10.1253/circj.cj-26-0652
UR  - https://www.jstage.jst.go.jp/article/circj/90/9/90_CJ-26-0652/_article
AB  - with lipid-rich or vulnerable plaque characteristics, including in non-flow-limiting non-culprit lesions of patients with MI. 3,4 Conversely, from a prognostic standpoint, lower PPG or diffuse disease patterns have also been associated with adverse vessel-related outcomes after PCI. 5 Thus, plaque vulnerability and clinical prognosis may represent related but distinct aspects of coronary disease.Our original discussion was intended to raise the hypothesis that a lower QFR-PPG phenotype may reflect a broader disease burden in AMI non-IRA lesions, rather than to establish a direct mechanistic link between low QFR-PPG and vulnerable plaque morphology.Further studies integrating coronary physiology with systematic intravascular imaging are needed to clarify the underlying plaque phenotype.Taken together, we agree that QFR-PPG <0.78 should be interpreted as a data-derived prognostic threshold rather than as a definitive biological definition of diffuse disease or plaque vulnerability.At the same time, the additional analyses demonstrate that QFR-PPG provides prognostic information not fully captured by QFR within the nonischemic range, particularly when combined with relatively lower QFR values.We therefore believe that the QFR/ QFR-PPG phenotype is best interpreted as a prognostic physiological risk-stratification tool for deferred, functionally insignificant intermediate non-IRA lesions after AMI.
SN  - 1347-4820
SN  - 1346-9843
ER  -